RU2009119567A - Уменьшение избыточной массы тела или ожирения - Google Patents
Уменьшение избыточной массы тела или ожирения Download PDFInfo
- Publication number
- RU2009119567A RU2009119567A RU2009119567/15A RU2009119567A RU2009119567A RU 2009119567 A RU2009119567 A RU 2009119567A RU 2009119567/15 A RU2009119567/15 A RU 2009119567/15A RU 2009119567 A RU2009119567 A RU 2009119567A RU 2009119567 A RU2009119567 A RU 2009119567A
- Authority
- RU
- Russia
- Prior art keywords
- obesity
- reducing
- overbody
- pharmaceutical composition
- use according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Fats And Perfumes (AREA)
- Pyridine Compounds (AREA)
Abstract
1. Применение O-(3-пиперидино-2-гидрокси-1-пропил)-никотинамидоксима или его фармацевтически приемлемой соли присоединения кислоты для получения фармацевтической композиции, пригодной для предотвращения аномального прироста массы тела или уменьшения избыточной массы тела или ожирения. ! 2. Применение по п.1, где применяют O-(3-пиперидино-2-гидрокси-1-пропил)-никотинамидоксимадигидрохлорид. ! 3. Применение по п.1 или 2, где фармацевтическую композицию применяют для уменьшения индекса массы тела, равного 25-30 кг/м2. ! 4. Применение по п.1 или 2, где фармацевтическую композицию применяют для уменьшения индекса массы тела, равного более 30 кг/м2.
Claims (4)
1. Применение O-(3-пиперидино-2-гидрокси-1-пропил)-никотинамидоксима или его фармацевтически приемлемой соли присоединения кислоты для получения фармацевтической композиции, пригодной для предотвращения аномального прироста массы тела или уменьшения избыточной массы тела или ожирения.
2. Применение по п.1, где применяют O-(3-пиперидино-2-гидрокси-1-пропил)-никотинамидоксимадигидрохлорид.
3. Применение по п.1 или 2, где фармацевтическую композицию применяют для уменьшения индекса массы тела, равного 25-30 кг/м2.
4. Применение по п.1 или 2, где фармацевтическую композицию применяют для уменьшения индекса массы тела, равного более 30 кг/м2.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85611706P | 2006-11-02 | 2006-11-02 | |
| US60/856,117 | 2006-11-02 | ||
| US11/687,945 US7763601B2 (en) | 2006-11-02 | 2007-03-19 | Prevention and treatment of obesity |
| US11/687,945 | 2007-03-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2009119567A true RU2009119567A (ru) | 2010-12-10 |
| RU2443417C2 RU2443417C2 (ru) | 2012-02-27 |
Family
ID=38592002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009119567/15A RU2443417C2 (ru) | 2006-11-02 | 2007-07-23 | Уменьшение избыточной массы тела или ожирения |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7763601B2 (ru) |
| EP (1) | EP2089031B1 (ru) |
| JP (1) | JP2010509199A (ru) |
| KR (1) | KR20090082442A (ru) |
| AT (1) | ATE489090T1 (ru) |
| AU (1) | AU2007315931A1 (ru) |
| BR (1) | BRPI0717867A2 (ru) |
| CA (1) | CA2668382A1 (ru) |
| DE (1) | DE602007010819D1 (ru) |
| DK (1) | DK2089031T3 (ru) |
| HK (1) | HK1131737A1 (ru) |
| HR (1) | HRP20110023T1 (ru) |
| IL (1) | IL198296A (ru) |
| MX (1) | MX2009004538A (ru) |
| NO (1) | NO20092025L (ru) |
| PL (1) | PL2089031T3 (ru) |
| PT (1) | PT2089031E (ru) |
| RU (1) | RU2443417C2 (ru) |
| SI (1) | SI2089031T1 (ru) |
| WO (1) | WO2008053256A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| EP3788877A1 (en) * | 2007-04-11 | 2021-03-10 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| WO2009074835A1 (en) * | 2007-12-10 | 2009-06-18 | N-Gene Research Laboratories Inc. | Dose reduction of a cannabinoid cb1 receptor antagonist in the treatment of overweight or obesity |
| HUP1100444A2 (en) | 2011-08-17 | 2013-02-28 | Pharma Gene Sa | Pharmaceutical composition |
| HUP1100445A2 (en) | 2011-08-17 | 2013-02-28 | Pharma Gene Sa | Pharmaceutical composition |
| HUP1800298A1 (hu) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4187220A (en) | 1977-08-30 | 1980-02-05 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| US4287220A (en) * | 1980-02-19 | 1981-09-01 | Frito-Lay, Inc. | Hull containing compositions |
| HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
| HU9502843D0 (en) | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
| US6884424B2 (en) | 1995-12-22 | 2005-04-26 | N-Gene Research Laboratories Inc. | Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight |
| US6458371B1 (en) | 1995-12-22 | 2002-10-01 | Medgene, Limited | Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin |
| HU9701081D0 (en) | 1997-06-23 | 1997-08-28 | Gene Research Lab Inc N | Pharmaceutical composition of antitumoral activity |
| HUP9701080A3 (en) | 1997-06-23 | 1999-05-28 | Gene Res Lab Inc New York N | Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative |
| AU5296799A (en) | 1998-08-03 | 2000-02-28 | N-Gene Kutato Kft. | Pharmaceutical compositions against autoimmune diseases |
| UA65635C2 (ru) * | 1998-09-03 | 2004-04-15 | Н-Гене Кутато Кфт. | НЕНАСЫЧЕННЫЕ ПРОИЗВОДНЫЕ ГИДРОКСИМОВОЙ КИСЛОТЫ, ИМЕЮЩИЕ СВОЙСТВА ИНГИБИТОРОВ NAD<sup>+-ADP-РИБОЗИЛТРАНСФЕРАЗЫ |
| CA2452558C (en) | 2001-07-17 | 2009-12-22 | N-Gene Research Laboratories Inc. | A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| HUP0401177A2 (en) | 2004-06-14 | 2007-09-28 | N Gene Res Lab Inc | Pharmaceutical composition for increasing the mitochondrial genesis |
| HUP0401176A2 (en) | 2004-06-14 | 2007-09-28 | N Gene Res Lab Inc | Pharmaceutical composition having prpkinetic effect |
| HUP0500145A2 (en) | 2005-01-28 | 2006-11-28 | Gene Res Lab N | Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases |
| CN101534836B (zh) | 2006-09-05 | 2011-09-28 | 彼帕科学公司 | Parp抑制剂在制备治疗肥胖症的药物中的用途 |
-
2007
- 2007-03-19 US US11/687,945 patent/US7763601B2/en not_active Expired - Fee Related
- 2007-07-23 CA CA002668382A patent/CA2668382A1/en not_active Abandoned
- 2007-07-23 DE DE602007010819T patent/DE602007010819D1/de active Active
- 2007-07-23 RU RU2009119567/15A patent/RU2443417C2/ru not_active IP Right Cessation
- 2007-07-23 AT AT07766498T patent/ATE489090T1/de active
- 2007-07-23 PT PT07766498T patent/PT2089031E/pt unknown
- 2007-07-23 WO PCT/HU2007/000066 patent/WO2008053256A1/en active Application Filing
- 2007-07-23 JP JP2009535137A patent/JP2010509199A/ja active Pending
- 2007-07-23 AU AU2007315931A patent/AU2007315931A1/en not_active Abandoned
- 2007-07-23 EP EP07766498A patent/EP2089031B1/en active Active
- 2007-07-23 PL PL07766498T patent/PL2089031T3/pl unknown
- 2007-07-23 DK DK07766498.5T patent/DK2089031T3/da active
- 2007-07-23 MX MX2009004538A patent/MX2009004538A/es active IP Right Grant
- 2007-07-23 BR BRPI0717867-0A patent/BRPI0717867A2/pt not_active IP Right Cessation
- 2007-07-23 SI SI200730517T patent/SI2089031T1/sl unknown
- 2007-07-23 KR KR1020097011079A patent/KR20090082442A/ko not_active Application Discontinuation
-
2009
- 2009-04-22 IL IL198296A patent/IL198296A/en not_active IP Right Cessation
- 2009-05-25 NO NO20092025A patent/NO20092025L/no not_active Application Discontinuation
- 2009-09-25 HK HK09108841.5A patent/HK1131737A1/xx not_active IP Right Cessation
-
2011
- 2011-01-13 HR HR20110023T patent/HRP20110023T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2089031T1 (sl) | 2011-04-29 |
| EP2089031A1 (en) | 2009-08-19 |
| IL198296A (en) | 2011-09-27 |
| BRPI0717867A2 (pt) | 2013-10-29 |
| WO2008053256A1 (en) | 2008-05-08 |
| PT2089031E (pt) | 2011-02-24 |
| NO20092025L (no) | 2009-06-02 |
| EP2089031B1 (en) | 2010-11-24 |
| DK2089031T3 (da) | 2011-02-14 |
| KR20090082442A (ko) | 2009-07-30 |
| ATE489090T1 (de) | 2010-12-15 |
| DE602007010819D1 (de) | 2011-01-05 |
| MX2009004538A (es) | 2009-05-22 |
| IL198296A0 (en) | 2010-02-17 |
| US7763601B2 (en) | 2010-07-27 |
| RU2443417C2 (ru) | 2012-02-27 |
| PL2089031T3 (pl) | 2011-05-31 |
| AU2007315931A1 (en) | 2008-05-08 |
| HK1131737A1 (en) | 2010-02-05 |
| CA2668382A1 (en) | 2008-05-08 |
| JP2010509199A (ja) | 2010-03-25 |
| US20080108673A1 (en) | 2008-05-08 |
| HRP20110023T1 (hr) | 2011-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009119567A (ru) | Уменьшение избыточной массы тела или ожирения | |
| WO2003064404A1 (fr) | Hydrazides d'acide 2-furancarboxylique et compositions pharmaceutiques les contenant | |
| WO2007127635A3 (en) | Diketo-piperazine and piperidine derivatives as antiviral agents | |
| WO2006010546A3 (en) | Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors | |
| NO330968B1 (no) | Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
| MX2012000414A (es) | Derivados piridin-4-ilo. | |
| MY143368A (en) | Pyrrazolo-pyrimidine derivatives | |
| WO2010136474A3 (en) | Substituted aminobutyric derivatives as neprilysin inhibitors | |
| CA2753382C (en) | Hepatitis c virus inhibitors | |
| MX2008002062A (es) | Uso de derivados de tienopiridona como activadores de ampk y composiciones farmaceuticas que los contienen. | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| CA2472954A1 (en) | Aza-arylpiperazines | |
| MX2011008119A (es) | Derivado de acido hialuronico polisulfatado de bajo peso molecular, y medicamento que contiene el mismo. | |
| DE602006021539D1 (en) | Morpholine als 5ht2c-agonisten | |
| TW200616958A (en) | New alkyl-pyridines as 11-beta inhibitors for diabetes | |
| WO2012004396A3 (en) | Process of preparing a thrombin specific inhibitor | |
| EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
| MY151072A (en) | Heteroaryl derivative | |
| MX2011011764A (es) | Compuestos de carboxamida y su uso como inhibidores de calpaina. | |
| UA89067C2 (ru) | Производные гидантоина, полезные как ингибиторы металлопротеиназ | |
| WO2007080270A3 (fr) | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation | |
| MX2012008509A (es) | Agente terapeutico o profilactic para enfermedades del tracto biliar. | |
| BRPI0514415A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| WO2011047055A8 (en) | Novel mek inhibitors, useful in the treatment of diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20150724 |